Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Alaunos Therapeutics, Inc. Common Stock (TCRT)

Pharmaceutical Preparations

https://www.alaunos.com

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens (neoAg) arising from genomic mutations.

8030 EL RIO STREET
HOUSTON, TX

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/24/2005

Market Cap

3,807,612

Shares Outstanding

240,630,000

Weighted SO

240,627,055

Total Employees

N/A

Upcoming Earnings

N/A

Beta

-0.4930

Last Div

0.0000

Range

2.29-33.0

Chg

0.0179

Avg Vol

12236

Mkt Cap

3807612

Exch

NASDAQ

Country

US

Phone

346 355 4099

DCF Diff

1.9776

DCF

0.3724

Div Yield

0.0000

P/S

634.6020

EV Multiple

-0.1085

P/FV

1.0097

Div Yield %

0.0000

P/E

-0.1990

PEG

-4.6527

Payout

0.0000

Current Ratio

5.1577

Quick Ratio

5.1577

Cash Ratio

2.7155

DSO

243.3333

DIO

0.0000

Op Cycle

243.3333

DPO

101.8540

CCC

141.4794

Gross Margin

-217.0000

Op Margin

-2488.6667

Pretax Margin

-3188.3333

Net Margin

-3188.3333

Eff Tax Rate

0.0361

ROA

-4.0894

ROE

-2.6593

ROCE

-3.9597

NI/EBT

1.0000

EBT/EBIT

1.2811

EBIT/Rev

-2488.6667

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

3.8865

CF/Debt

0.0000

Equity Multi

1.2405

Rec Turnover

1.5000

Pay Turnover

3.5836

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0013

OCF/Share

-10.8396

FCF/Share

-10.8403

Cash/Share

1.5382

OCF/Sales

-2892.8333

FCF/OCF

1.0001

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

-17357.0000

Div&CapEx Cov

-17357.0000

P/BV

1.0097

P/B

1.0097

P/S

634.6020

P/E

-0.1990

P/FCF

-0.2194

P/OCF

-0.2194

P/CF

-0.2194

PEG

-4.6527

P/S

634.6020

EV Multiple

-0.1085

P/FV

1.0097

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation